P. E. M. Fine
Impact in
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology
- Leprosy Research and Treatment
- Modeling and Simulation top 2%
- COVID-19 epidemiological studies
Papers in
-
- Tuberculosis Research and Epidemiology 21
- Leprosy Research and Treatment 21
- Epidemiology 16
- Mycobacterium research and diagnosis 6
- Pneumocystis jirovecii pneumonia detection and treatment 3
- Co-authors
- Laura C. Rodrigues (2 shared papers)J. M. Pönnighaus (10 shared papers)Amelia C. Crampin (8 shared papers)Lyn Bliss (7 shared papers)Judith R. Glynn (5 shared papers)N. Maine (3 shared papers)Jonathan A C Sterne (8 shared papers)W. A. Orenstein (1 shared paper)
- Journals
- Leprosy Review (10 papers)The Lancet (3 papers)Epidemiology and Infection (2 papers)Sexually Transmitted Infections (1 paper)Transactions of the Royal Society of Tropical Medicine and Hygiene (1 paper)
- Partner nations
- United KingdomMalawiGermany
In The Last Decade
P. E. M. Fine
48 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 96
- Infectious Diseases 930
- Modeling and Simulation 127
- Epidemiology 461
- Immunology 274
- Virology 32
Countries citing papers authored by P. E. M. Fine
This map shows the geographic impact of P. E. M. Fine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. E. M. Fine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. E. M. Fine more than expected).
Fields of papers citing papers by P. E. M. Fine
This network shows the impact of papers produced by P. E. M. Fine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. E. M. Fine. The network helps show where P. E. M. Fine may publish in the future.
Co-authors
The 25 scholars most cited alongside P. E. M. Fine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. | 1996 | 215 |
| 2 | 2003 | 196 | |
| 3 | 1990 | 111 | |
| 4 | Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis. An epidemiological perspective. | 1981 | 74 |
| 5 | The distribution and implications of BCG scars in northern Malawi. | 1989 | 62 |
| 6 | What has Karonga taught us? Tuberculosis studied over three decades. | 2009 | 54 |
| 7 | 1987 | 43 | |
| 8 | 2007 | 40 | |
| 9 | Stopping a polio outbreak in the post-eradication era. | 2001 | 35 |
| 10 | 1985 | 33 | |
| 11 | Incidence rates of leprosy in Karonga District, northern Malawi: patterns by age, sex, BCG status and classification. | 1994 | 32 |
| 12 | 2007 | 32 | |
| 13 | 2007 | 31 | |
| 14 | 1993 | 30 | |
| 15 | Extended schooling and good housing conditions are associated with reduced risk of leprosy in rural Malawi. | 1994 | 30 |
| 16 | 1995 | 27 | |
| 17 | Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998. | 2000 | 25 |
| 18 | 2008 | 24 | |
| 19 | Certainty levels in the diagnosis of leprosy. | 1987 | 24 |
| 20 | Four-year follow-up results of a WHO-recommended multiple-drug regimen in paucibacillary leprosy patients in Malawi. | 1991 | 24 |
About P. E. M. Fine
P. E. M. Fine is a scholar working on Infectious Diseases, Epidemiology, Immunology, Public Health, Environmental and Occupational Health and Economics and Econometrics, having authored 49 papers that have together received 1.4k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (21 papers), Leprosy Research and Treatment (21 papers), Mycobacterium research and diagnosis (6 papers), Immune responses and vaccinations (5 papers), HIV/AIDS Impact and Responses (4 papers), Zoonotic diseases and public health (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Infectious Diseases (930 citations), Modeling and Simulation (127 citations), Epidemiology (461 citations), Immunology (274 citations) and Virology (32 citations). P. E. M. Fine has collaborated with scholars based in United Kingdom, Malawi and Germany. Frequent co-authors include Laura C. Rodrigues, J. M. Pönnighaus, J. M. Pönnighaus, Amelia C. Crampin, Lyn Bliss, Judith R. Glynn, N. Maine, Jonathan A C Sterne, W. A. Orenstein and R. W. Sutter. Their work appears in journals such as Leprosy Review, The Lancet, Epidemiology and Infection, Sexually Transmitted Infections and Transactions of the Royal Society of Tropical Medicine and Hygiene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.